MENU
+Compare
ILMN
Stock ticker: NASDAQ
AS OF
Nov 21 closing price
Price
$123.85
Change
+$4.59 (+3.85%)
Capitalization
18.92B

ILMN Illumina Forecast, Technical & Fundamental Analysis

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications... Show more

Industry: #Biotechnology
ILMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ILMN with price predictions
Nov 21, 2025

ILMN sees MACD Histogram just turned negative

ILMN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ILMN moved out of overbought territory on November 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where ILMN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ILMN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ILMN broke above its upper Bollinger Band on October 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 21, 2025. You may want to consider a long position or call options on ILMN as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ILMN moved above its 50-day moving average on October 30, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ILMN crossed bullishly above the 50-day moving average on October 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where ILMN advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 178 cases where ILMN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ILMN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.949) is normal, around the industry mean (12.405). P/E Ratio (27.769) is within average values for comparable stocks, (134.795). Projected Growth (PEG Ratio) (0.617) is also within normal values, averaging (1.915). ILMN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (4.550) is also within normal values, averaging (9.817).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ILMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
ILMN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ILMN is expected to report earnings to fall 10.45% to $1.20 per share on February 05

Illumina ILMN Stock Earnings Reports
Q4'25
Est.
$1.20
Q3'25
Beat
by $0.17
Q2'25
Beat
by $0.18
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.03
The last earnings report on October 30 showed earnings per share of $1.34, beating the estimate of $1.17. With 2.37M shares outstanding, the current market capitalization sits at 18.92B.
A.I. Advisor
published General Information

General Information

a manufacturer of integrated systems for the analysis of genetic variation and function

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
5200 Illumina Way
Phone
+1 858 202-4500
Employees
10670
Web
https://www.illumina.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ENO22.580.28
+1.28%
Entergy New Orleans LLC
DAUG43.350.20
+0.47%
FT Vest US Equity Deep Bfr ETF Aug
IBHJ26.470.10
+0.36%
iShares iBonds 2030 Term Hi Yld & IncETF
NUV9.040.01
+0.11%
Nuveen Municipal Value Fund
QQJG25.82N/A
N/A
Invesco ESG NASDAQ Next Gen 100 ETF

ILMN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with RVTY. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
+3.85%
RVTY - ILMN
64%
Loosely correlated
+4.52%
A - ILMN
64%
Loosely correlated
+4.27%
MTD - ILMN
62%
Loosely correlated
+3.78%
TMO - ILMN
61%
Loosely correlated
+2.57%
BRKR - ILMN
60%
Loosely correlated
+7.82%
More

Groups containing ILMN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
+3.85%
ILMN
(4 stocks)
76%
Closely correlated
+3.80%